Updating results

899 results for Women's health

Sort: Date | Relevance

Diabetes

Everything NICE has said on managing type 1 and 2 diabetes in children, young people and adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2018

NICE impact: cardiovascular disease prevention

How NICE recommendations are helping to improve the prevention of cardiovascular disease

Published May 2018 Last updated May 2018

Bipolar disorder

Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

NICE Pathway Published September 2014 Last updated May 2018

Point-of-care diagnostic testing in primary care for strep A infection in sore throat (MIB145)

Advice on the use of point-of-care diagnostic testing in primary care for streptococcus A (strep A) infection in sore throat to aid local decision-making

Medtech innovation briefing Published May 2018

Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144)

Advice on the use of Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema to aid local decision-making

Medtech innovation briefing Published April 2018

Antenatal and postnatal mental health

Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart

NICE Pathway Published November 2011 Last updated April 2018

Epilepsy

Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

NICE Pathway Published January 2012 Last updated April 2018

Depression in adults: recognition and management (CG90)

This guideline covers identifying and managing depression in adults aged 18 years and older, in primary and secondary care. It aims to improve care for people with depression by promoting improved recognition and treatment.

Clinical guideline Published October 2009 Last updated April 2018

Epilepsies: diagnosis and management (CG137)

The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life

Clinical guideline Published January 2012 Last updated April 2018

Antenatal and postnatal mental health: clinical management and service guidance (CG192)

This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.

Clinical guideline Published December 2014 Last updated April 2018

Bipolar disorder: assessment and management (CG185)

This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.

Clinical guideline Published September 2014 Last updated April 2018

ColonFlag for identifying people at risk of colorectal cancer (MIB142)

Advice on the use of ColonFlag (web-based machine learning algorithm) for identifying people at risk of colorectal (bowel) cancer to aid local decision-making

Medtech innovation briefing Published April 2018

New advice will help doctors spot and treat Lyme disease early, says NICE

NICE has issued new advice to help doctors quickly spot Lyme disease, so they can offer people NHS treatment as soon as possible.

News Published April 2018 Last updated April 2018

Care and support of people growing older with learning disabilities (NG96)

This guideline covers care and support for adults with learning disabilities as they grow older. It covers identifying changing needs, planning for the future, and delivering services including health, social care and housing. It aims to support people to access the services they need as they get older.

NICE guideline Published April 2018

Help people make informed decisions when they want to quit smoking, says NICE and Public Health England.

NICE and Public Health England have published updated guidelines for health practitioners and stop smoking services on the best ways to help people quit smoking.

News Published March 2018 Last updated March 2018

Otitis media (acute): antimicrobial prescribing (NG91)

This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without antibiotics. Serious complications are rare.

Antimicrobial prescribing guideline Published March 2018

Stop smoking interventions and services (NG92)

This guideline covers stop smoking interventions and services delivered in primary care and community settings for everyone over the age of 12. It aims to ensure that everyone who smokes is advised and encouraged to stop and given the support they need. It emphasises the importance of targeting vulnerable groups who find smoking cessation hard or who smoke a lot.

NICE guideline Published March 2018

Physical activity and the environment (NG90)

This guideline covers how to improve the physical environment to encourage and support physical activity. The aim is to increase the general population’s physical activity levels.

NICE guideline Published March 2018

Venous thromboembolism in adults: reducing the risk in hospital (QS3)

This quality standard covers reducing the risk of venous thromboembolism (VTE) in adults who are in hospital. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It covers people admitted as inpatients and those admitted to a hospital bed as day-case patients, including women who are pregnant and women after childbirth. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2010 Last updated March 2018

Heavy menstrual bleeding (QS47)

This quality standard covers assessing and managing heavy menstrual bleeding (also called menorrhagia or heavy periods). It includes assessment, diagnosis, and drug and surgical treatment options, including treatments for uterine fibroids associated with heavy menstrual bleeding. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2013 Last updated March 2018

Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke (MIB141)

Advice on the use of Reveal LINQ insertable cardiac monitor (ICM) to detect atrial fibrillation (AF) after cryptogenic stroke to aid local decision-making

Medtech innovation briefing Published February 2018

Coban 2 for venous leg ulcers (MIB140)

Advice on the use of Coban 2 for venous leg ulcers to aid local decision-making

Medtech innovation briefing Published February 2018

Aortic valve reconstruction with processed bovine pericardium (IPG604)

Evidence-based recommendations on aortic valve reconstruction with processed bovine pericardium (using new valve made from chemically treated cow pericardium)

Interventional procedures guidance Published February 2018

Once a day pill for ovarian cancer could be made available on the CDF

NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund (CDF), for treating some types of recurrent ovarian cancer.

News Published February 2018 Last updated February 2018

Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (TA160)

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance Published October 2008 Last updated February 2018

Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (TA161)

Evidence-based recommendations on raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance Published October 2008 Last updated February 2018

Lesinurad for treating chronic hyperuricaemia in people with gout (TA506)

Evidence-based recommendations on lesinurad (Zurampic) for treating chronic hyperuricaemia (too much uric acid/urate in blood) in adults with gout

Technology appraisal guidance Published February 2018

Intrabeam radiotherapy system for adjuvant treatment of early breast cancer (TA501)

Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery for adults with early breast cancer

Technology appraisal guidance Published January 2018

Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer (TA503)

Evidence-based recommendations on fulvestrant (Faslodex) for untreated locally advanced or metastatic (secondary) oestrogen-receptor positive breast cancer in

Technology appraisal guidance Published January 2018

EpiFix for chronic wounds (MIB139)

Advice on the use of EpiFix (an allograft comprising dehydrated human amnion/chorion membrane tissue/dHACM) for chronic wounds to aid local decision-making

Medtech innovation briefing Published January 2018

Sore throat (acute): antimicrobial prescribing (NG84)

This guideline sets out an antimicrobial prescribing strategy for acute sore throat. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sore throat is often caused by a virus, lasts for about a week, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.

Antimicrobial prescribing guideline Published January 2018

MammaTyper in vitro diagnostic test for determining breast cancer subtypes (MIB135)

Advice on the use of the MammaTyper in vitro diagnostic test for determining breast cancer subtypes to aid local decision-making

Medtech innovation briefing Published January 2018

Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)

Advice on the use of point-of-care (POC) creatinine tests for measuring kidney function before contrast-enhanced imaging to aid local decision-making

Medtech innovation briefing Published January 2018

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (MIB137)

Advice on the use of plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published January 2018

TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum (MIB134)

Advice on the use of the TYM smartphone otoscope (using Apple iOS device) for imaging/videoing the external ear canal and eardrum to aid local decision-making

Medtech innovation briefing Published January 2018

Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA495)

Evidence-based recommendations on palbociclib (Ibrance) as initial endocrine-based therapy for hormone receptor-positive, HER2-negative, locally advanced or

Technology appraisal guidance Published December 2017

Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA496)

Evidence-based recommendations on ribociclib (Kisqali) as initial endocrine-based therapy for hormone-receptor positive, human epidermal growth factor receptor

Technology appraisal guidance Published December 2017

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)

Evidence-based recommendations on point-of-care coagulometers (the CoaguChek XS system) to self-monitor blood clotting

Diagnostics guidance Published September 2014 Last updated December 2017

Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (TA490)

Evidence-based recommendations on nivolumab (Opdivo) for squamous cell carcinoma (SCC) of the head and neck in adults who have had platinum-based chemotherapy

Technology appraisal guidance Published November 2017

Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane (TA458)

Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for treating advanced HER2-positive breast cancer that has been treated before

Technology appraisal guidance Published July 2017 Last updated November 2017

Health app: GDm-Health for people with gestational diabetes (MIB131)

Advice on the GDm-Health app to remotely monitor blood glucose in people with gestational diabetes (diabetes in pregnancy) to aid local decision-making

Medtech innovation briefing Published November 2017

Health app: Sleepio for adults with poor sleep (MIB129)

Advice on the use of the Sleepio health app to help adults with poor sleep improve sleep through cognitive behavioural therapy, to aid local decision-making

Medtech innovation briefing Published November 2017

Health app: ChatHealth communication platform in school nursing services (MIB130)

Advice on the use of the ChatHealth app for anonymous and confidential communication between patients and healthcare professionals in school nursing services

Medtech innovation briefing Published November 2017

Familial hypercholesterolaemia: identification and management (CG71)

This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.

Clinical guideline Published August 2008 Last updated November 2017

Radiation dose monitoring software for medical imaging with ionising radiation (MIB127)

Advice on the use of radiation dose monitoring software for medical imaging with ionising radiation to aid local decision-making

Medtech innovation briefing Published October 2017

Hepatitis B (chronic): diagnosis and management (CG165)

This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.

Clinical guideline Published June 2013 Last updated October 2017

Immunosuppressive therapy for kidney transplant in adults (TA481)

Evidence-based recommendations on immunosuppressive therapies for preventing kidney rejection in adults

Technology appraisal guidance Published October 2017

Immunisations for under 19s

Everything NICE has said on immunisation in under 19s in an interactive flowchart

NICE Pathway Published October 2011 Last updated October 2017

Child abuse and neglect (NG76)

This guideline covers recognising and responding to abuse and neglect in children and young people aged under 18. It covers physical, sexual and emotional abuse, and neglect. The guideline aims to help anyone whose work brings them into contact with children and young people to spot signs of abuse and neglect and to know how to respond. It also supports practitioners who carry out assessments and provide early help and interventions to children, young people, parents and carers.

NICE guideline Published October 2017